1Title | Effects of care of multimorbid patientes in general practices by advanced practice nurses: study protocol for a nonrandomized controlled trial | |
---|---|---|
2a and 2b Trial registration | 2a: Registry: DRKS00026172 on DRKS (German Clinical Trials Register) 2b: Data Set: | |
Data category | Information | |
Primary registry and trial identifying number | DRKS00026172 on DRKS | |
Date of registration in primary registry | 2021/09/06 | |
Secondary identifying numbers | n/a | |
Source(s) of monetary or material support | German Innovation Fund of the Federal Joint Committee | |
Primary sponsor | German Innovation Fund of the Federal Joint Committee | |
Secondary sponsor(s) | n/a | |
Contact for public queries | Catholic University of Applied Sciences Mainz Prof. Dr. Renate Stemmer Saarstr. 3 55122 Mainz Germany Telephone: + 496131 28944 520 stemmer@kh-mz.de | |
Contact for scientific queries | Catholic University of Applied Sciences Mainz Prof. Dr. Renate Stemmer Saarstr. 3 55122 Mainz Germany Telephone: + 496131 28944 520 stemmer@kh-mz.de | |
Public title | Case-based care of multimorbid patients in general practice by advanced practice nurses (APNs) | |
Scientific title | Effects of care of multimorbid patients in general practices by advanced practice nurses (FAMOUS): study protocol for a nonrandomized controlled trial | |
Country of recruitment | Germany | |
Health condition(s) or problem(s) studied | Multimorbidity | |
Intervention(s) | Intervention group: GP-oriented care of multimorbid patients by APNs. Qualification profile of APNs: professional nursing licence, at least 2 years of professional experience in nursing, academic degree at master’s level, 500 hours project-specific advanced training. Task profile: in-depth assessment, preparation, monitoring and evaluation of a person-centred and evidence-based care plan. Control group: multimorbid patients receiving standard care. | |
Key inclusion and exclusion criteria | Gender: all genders Minimum age: ≥ 18 years Maximum age: no maximum age Further inclusion criteria: medical diagnosis of at least three chronic diseases, which in the past 12 months in at least three out of four quarters have given rise to general practitioners’ treatment;being in general practitioners’ treatment; insurance with a statutory health insurance company. Exclusion criteria: not fulfilling the inclusion criteria; being in the dying phase according to the assessment of the general practitioner. | |
Study type | Interventional, nonrandomized, nonblinded controlled trial | |
Date of first enrolment | 2021/10/01 | |
Target sample size | n=2451 | |
Recruitment status | Recruiting | |
Primary outcome(s) | Number of emergency contacts | |
Key secondary outcomes | Use of other health care facilities (e.g. hospital, nursing home), hospital readmission and visits by general practitioners | |
3 Protocol version | Issue Date: 2021/10/01 | |
4 Funding | There was financial support only, provided by the German Innovation Fund of the Federal Joint Committee. The Innovation Fund uses funds from the statutory health insurance (SHI) to support innovative, cross-sectoral new forms of care and patient-oriented care research projects in order to further develop and improve SHI-financed care in Germany | |
5a Author details | RS and EG initiated the study design; CDS is responsible for the project management; JK developed the concept of the internal evaluation and will conduct it. EG and MB developed the concept of the external evaluation; BB and MB together with a statistician are planning and will conduct the statistical analysis. BB is responsible for the implementation of the qualitative interviews. All authors contributed to the development and refinement of the study protocol and approved the final manuscript. | |
5b Name and contact information for the trial sponsor | Trial Sponsor: Catholic University of Applied Sciences Mainz (CUAS) Contact name: Prof. Dr. Renate Stemmer Address: 55122 Mainz, Saarstr. 3, Germany Telephone: + 49613128944520 Email: stemmer@kh-mz.de | |
5c Role of funder | This funding source had no role in the design of this study and will not have any role during its execution, analyses, interpretation of the data, or decision to submit results. |